While CD44 isoform usage and epithelial splicing regulators ESRP1/2 are well-characterized in cancer-associated epithelial-mesenchymal transition (EMT), their regulation across physiological, non-transformed identity states remains less well defined. This evidence concerns the gene CD44 and cancer.